CS logo
small CS logo
Centrum Medyczne Pratia Czestochowa

Czestochowa, Poland
Medical center in Częstochowa
ul, 3 Maja 16, 42-200 Częstochowa

About Centrum Medyczne Pratia Czestochowa


"Pratia Częstochowa to jeden z ośrodków badań klinicznych należący do największej sieci ośrodków badań klinicznych w Polsce – Pratia. Pratia powstała w trosce o pacjentów, którzy zmagają się z chorobami przewlekłymi i chcą uzyskać dostęp do nowoczesnych metod leczenia, które są w fazie badań klinicznych. Prowadzimy badania w ponad 20 obszarach terapeutycznych między innymi w dermatologi, diabetologi, gastroenterologi, ginekologi, laryngologi, immunologi, kardiologi, neurologi, nefrologi, onkologi, ortopedia pediatrii, pulmonologi, reumatologi, a także badania dotyczące szczepionek. Badania kliniczne proponowane naszym pacjentom uzyskały zgodę Ministerstwa Zdrowia oraz mają pozytywną opinię niezależnej Komisji Bioetycznej."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centrum Medyczne Pratia Czestochowa


During the past decade, Centrum Medyczne Pratia Czestochowa conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 8 clinical trials were completed, i.e. on average, 61.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Centrum Medyczne Pratia Czestochowa" #1 sponsor was "Shire" with 5 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "ALK-Abelló A/S" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Medyczne Pratia Czestochowa" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Centrum Medyczne Pratia Czestochowa


According to Clinical.Site data, the most researched conditions in "Centrum Medyczne Pratia Czestochowa" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (3 trials), "Active Systemic Lupus Erythematosus" (1 trials), "Allergy" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Centrum Medyczne Pratia Czestochowa" in a lesser frequency.

Clinical Trials Intervention Types at Centrum Medyczne Pratia Czestochowa


Most popular intervention types in "Centrum Medyczne Pratia Czestochowa" are "Drug" (12 trials), "Other" (5 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Ontamalimab" (4 trials), "Etrasimod" (3 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centrum Medyczne Pratia Czestochowa


The vast majority of trials in "Centrum Medyczne Pratia Czestochowa" are 13 trials for "All" genders.

Clinical Trials Status at Centrum Medyczne Pratia Czestochowa


Currently, there are NaN active trials in "Centrum Medyczne Pratia Czestochowa". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centrum Medyczne Pratia Czestochowa, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Medyczne Pratia Czestochowa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".